BPC-157 vs Wolverine blend
Written by Aaron CuhaReviewed Sep 2026
The short answer
A single peptide against the blend built around it. Wolverine is usually 10 mg each of BPC-157 and what is sold as TB-500, and no study has tested the pair. So the blend cannot have more evidence than its parts, and it adds one more doubt about what the second part really is.
- BPC-157 people
- 31
- BPC-157 nulls
- 1
- Wolverine blend people
- 0
- Wolverine blend nulls
- 0
Dose
No human dose established
No published study has given BPC-157 as a shot under the skin or as a pill, the ways most buyers take it. Amounts that circulate in forums are not a human dose. Amounts that were given in studies sit in Human evidence on this page.
Commonly reported amounts, in mcg. BPC-157 has no approved label and no completed human dosing trial.
Amounts commonly reported by people buying BPC-157, recorded for this archive's reconstitution calculator, are 250, 500 and 750 mcg. They are self-reports rather than trial doses, and this archive does not recommend any of them. No human dose has been established for BPC-157.
| Reported amount | Where the number comes from |
|---|---|
| 250 mcg | Commonly reported, no published human dosing trial |
| 500 mcg | Commonly reported, no published human dosing trial |
| 750 mcg | Commonly reported, no published human dosing trial |
Dose
No human dose established
Amounts that circulate in forums and on vendor pages are not a human dose. No published study on this page has given this compound to people and reported a result.
Amounts for the BPC-157 in the blend, in mcg, commonly reported. The TB-500 moves with it in the label ratio.
Amounts commonly reported for the BPC-157 in this blend, recorded for this archive's reconstitution calculator, are 250, 500 and 750 mcg. They are self-reports rather than trial doses, and this archive does not recommend any of them. No human dose has been established for Wolverine blend.
| Reported amount | Where the number comes from |
|---|---|
| 250 mcg | Commonly reported, no published human dosing trial |
| 500 mcg | Commonly reported, no published human dosing trial |
| 750 mcg | Commonly reported, no published human dosing trial |
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
BPC-157Body Protection Compound 157
A lab-made piece of a stomach protein. It has lots of animal studies on tendon, muscle and gut healing. In people there is very little: two enema studies in Croatia, three small clinic reports with nobody to compare against, and one injury study with a dummy group that is still signing people up.
Column B
Wolverine blendWolverine (BPC-157 + TB-500)
Two gray-market healing peptides in one vial, usually 10 mg of each, sold for injury recovery. No study has ever tested the two together. A review of BPC-157 found 36 studies, and 35 of them were in animals or cells. And what shops sell as TB-500 is not thymosin beta 4. It is a seven amino acid piece of it.
Side by side, on the facts we can check
| What we compare | BPC-157 | Wolverine blend |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| FDA status | Not FDA-approved. In April 2026 the FDA took it off Category 2, its list of pharmacy ingredients with safety worries. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with one member abstaining, in favor of letting pharmacies make it. The FDA's own reviewers had advised against that. The FDA has not acted yet | Not approved, and the combination has never been reviewed. FDA staff looked at BPC-157 for the July 2026 meeting of the Pharmacy Compounding Advisory Committee, the panel that advises on what pharmacies may mix. They found no adequate human data, and they found wrongly labelled products on the market. Neither part is an approved medicine anywhere. |
| Half-life | Under 30 minutes in plasma in a two-person pilot; the animal literature describes effects lasting hours to days. | Not defined for the blend, and the components differ. A systematic review reports BPC-157 as hepatically metabolised with a half-life under 30 minutes and renal clearance. |
| Molecular weight | 1,419.5 Da | A mixture. BPC-157 is about 1,419 Da. The Ac-LKKTETQ fragment identified in TB-500 is about 861 Da, well short of the roughly 4,960 Da of full-length thymosin beta 4. |
| How it works | In animals, BPC-157 helps grow new blood vessels. It works with nitric oxide, a gas the body uses to widen blood vessels. In tendon cells from animals, it raises growth hormone receptors and growth signals. Nobody has found the exact switch it acts on. The FDA's 2026 review gave that as one reason it could not judge whether it should work. In people, very little is known. After an enema, it could not be found in the blood. A two-person test suggests it leaves the blood in under 30 minutes. Animal studies describe effects that last hours to days. | People assume the effects add up, and assume is the key word. In animal and lab studies, BPC-157 is reported to raise growth hormone receptors and switch on pathways for cell growth and new blood vessels, while lowering inflammation signals. The full thymosin beta 4 protein grabs actin, a building block of the cell's frame, and helps cells move. The small piece actually in TB-500 sits inside the part of the protein that grabs actin. No paper describes what happens when the two are given together. Nobody knows if they add up, overlap or get in each other's way, or even if they stay stable mixed in one vial. |
| Studies in people | 7 | 1 |
| Evidence | Limited: 3 completed trials, 31 people given it | Preliminary: 1 registered with no result |
| Legal status, US | Not approved; research use only | Not approved; research use only |
Frequently asked questions
What is the difference between BPC-157 and Wolverine blend?
BPC-157: A lab-made piece of a stomach protein. It has lots of animal studies on tendon, muscle and gut healing. In people there is very little: two enema studies in Croatia, three small clinic reports with nobody to compare against, and one injury study with a dummy group that is still signing people up. Wolverine blend: Two gray-market healing peptides in one vial, usually 10 mg of each, sold for injury recovery. No study has ever tested the two together. A review of BPC-157 found 36 studies, and 35 of them were in animals or cells. And what shops sell as TB-500 is not thymosin beta 4. It is a seven amino acid piece of it.
Which has stronger research evidence, BPC-157 or Wolverine blend?
Each compound gets a band worked out from facts we counted, with the math shown. BPC-157 is Limited (3 completed trials, 31 people given it). Wolverine blend is Preliminary (1 registered with no result). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are BPC-157 and Wolverine blend FDA-approved?
BPC-157: Not FDA-approved. In April 2026 the FDA took it off Category 2, its list of pharmacy ingredients with safety worries. In July 2026 the FDA's Pharmacy Compounding Advisory Committee voted 8 to 6, with one member abstaining, in favor of letting pharmacies make it. The FDA's own reviewers had advised against that. The FDA has not acted yet. Wolverine blend: Not approved, and the combination has never been reviewed. FDA staff looked at BPC-157 for the July 2026 meeting of the Pharmacy Compounding Advisory Committee, the panel that advises on what pharmacies may mix. They found no adequate human data, and they found wrongly labelled products on the market. Neither part is an approved medicine anywhere..
Related posts
Blog articles that cover BPC-157 or Wolverine blend, newest first.
- Healing & Recovery / Sep 27, 2026 / 9 minPeptides for Joint Pain: BPC-157, TB-500, Lorecivivint, Pentosan and Collagen Peptides, Evidence Tiered
- Healing & Recovery / Sep 27, 2026 / 8 minPeptides for Gut Health: BPC-157, KPV and Larazotide Ranked by Human Evidence
- Safety / Sep 27, 2026 / 9 minPeptide Side Effects by Class: What Is Documented, What Is Anecdotal
- Safety / Sep 27, 2026 / 8 minHow to Read a Peptide Certificate of Analysis: HPLC Purity, Mass Spec Identity, Endotoxin, and Janoshik Verification
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.